Shao-Hui Hu1, Yi Guang2, Wei-Xing Wang3. 1. Department of Hepatobiliary and Laparoscopic Surgery, Renmin Hospital of Wuhan University, No. 238, Jiefang Road, No. 99, Zhang Zhidong Road (Formerly Ziyang Road), Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China. 2. Department of Gynecology, Xiaogan Central Hospital, Xiaogan, 432000, Hubei Province, People's Republic of China. 3. Department of Hepatobiliary and Laparoscopic Surgery, Renmin Hospital of Wuhan University, No. 238, Jiefang Road, No. 99, Zhang Zhidong Road (Formerly Ziyang Road), Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China. wxw_wxw_001@126.com.
Abstract
BACKGROUND: Calcitonin gene-related peptide (CGRP) has antioxidant and anti-inflammatory activities on the pathological damage of acute pancreatitis. However, its molecular mechanism on severe acute pancreatitis (SAP) remains unknown. AIMS: To evaluate the influence of CGRP-mediated p38MAPK signaling pathway in rats with SAP. METHODS: SD rats were randomly divided into Sham group, SAP group, CGRP group (SAP rats injected with CGRP), SB203580 group (rats injected with p38MAPK pathway inhibitor SB203580), and CGRP8-37 group (SAP rats injected with CGRP8-37). Serum amylase and lipase activities were determined. Histopathological observations were evaluated, and the expression of inflammatory cytokines and oxidative stress-related indexes were measured. RESULTS: Compared with Sham group, SAP rats were increased in the activities of serum amylase and lipase, the pathologic assessment of pancreatic tissue, the levels of TNF-α, IL-1β, IL-6, and IL-8, the content of MDA and MPO, and the expressions of CGRP, and p-p38MAPK protein, but they were decreased in SOD activity and GSH content. The above alterations were aggravated in the CGRP8-37 group when compared with SAP group. Besides, in comparison with SAP group, rats in the CGRP and SB203580 groups presented a reduction in the activities of serum amylase and lipase, the levels of inflammatory cytokines, the content of MDA and MPO, and the expressions of p-p38MAPK protein, while showed an elevation in SOD activity and GSH content. CONCLUSION: Pretreatment with CGRP alleviated oxidative stress and inflammatory response of SAP rats possibly by suppressing the activity of p38MAPK pathway, and thereby postponing the disease progression.
BACKGROUND:Calcitonin gene-related peptide (CGRP) has antioxidant and anti-inflammatory activities on the pathological damage of acute pancreatitis. However, its molecular mechanism on severe acute pancreatitis (SAP) remains unknown. AIMS: To evaluate the influence of CGRP-mediated p38MAPK signaling pathway in rats with SAP. METHODS: SD rats were randomly divided into Sham group, SAP group, CGRP group (SAP rats injected with CGRP), SB203580 group (rats injected with p38MAPK pathway inhibitor SB203580), and CGRP8-37 group (SAP rats injected with CGRP8-37). Serum amylase and lipase activities were determined. Histopathological observations were evaluated, and the expression of inflammatory cytokines and oxidative stress-related indexes were measured. RESULTS: Compared with Sham group, SAP rats were increased in the activities of serum amylase and lipase, the pathologic assessment of pancreatic tissue, the levels of TNF-α, IL-1β, IL-6, and IL-8, the content of MDA and MPO, and the expressions of CGRP, and p-p38MAPK protein, but they were decreased in SOD activity and GSH content. The above alterations were aggravated in the CGRP8-37 group when compared with SAP group. Besides, in comparison with SAP group, rats in the CGRP and SB203580 groups presented a reduction in the activities of serum amylase and lipase, the levels of inflammatory cytokines, the content of MDA and MPO, and the expressions of p-p38MAPK protein, while showed an elevation in SOD activity and GSH content. CONCLUSION: Pretreatment with CGRP alleviated oxidative stress and inflammatory response of SAP rats possibly by suppressing the activity of p38MAPK pathway, and thereby postponing the disease progression.
Authors: Z Warzecha; A Dembiński; P Ceranowicz; P C Konturek; J Stachura; R Tomaszewska; S J Konturek Journal: J Physiol Pharmacol Date: 1999-03 Impact factor: 3.011
Authors: Bettina Rau; Katja Baumgart; Colin M Krüger; Martin Schilling; Hans G Beger Journal: Intensive Care Med Date: 2003-02-15 Impact factor: 17.440
Authors: Lai S Tam; Edmund K Li; Vivian Y F Leung; James F Griffith; Iris F F Benzie; Pak L Lim; Bruce Whitney; Vivian W Y Lee; Kenneth K C Lee; G Neil Thomas; Brian Tomlinson Journal: J Rheumatol Date: 2005-02 Impact factor: 4.666
Authors: Chris M Olson; Michael N Hedrick; Hooman Izadi; Tonya C Bates; Elias R Olivera; Juan Anguita Journal: Infect Immun Date: 2006-10-30 Impact factor: 3.441
Authors: Javier Pereda; Luis Sabater; Luis Aparisi; Javier Escobar; Juan Sandoval; José Viña; Gerardo López-Rodas; Juan Sastre Journal: Curr Med Chem Date: 2006 Impact factor: 4.530